Fibroscan (Liver Stiffness)

A Painless Window Into Liver Health, Without a Biopsy

For many years, a liver biopsy was the only reliable way to know how much scarring, or fibrosis, was present in the liver. FibroScan changed that. It is a non-invasive, ultrasound-based test that measures liver stiffness in minutes, in an outpatient setting, without needles or sedation and for the majority of patients, it now removes the need for a biopsy altogether.

FibroScan reports two separate measurements: liver stiffness, measured in kilopascals (kPa), which correlates with the degree of fibrosis, and the Controlled Attenuation Parameter (CAP), which estimates the amount of fat in the liver. Together, these give a detailed, immediate picture of two of the most important aspects of liver health.

At the practice of Dr. Ashok Choudhury, FibroScan is used as a first-line tool across a wide range of liver conditions, helping guide diagnosis, monitor disease over time, and reduce the need for invasive testing wherever possible.

FibroScan Makes Liver Assessment Simple and Accessible

A quick test with real clinical value

Many patients are understandably anxious when a liver test is recommended, particularly if they associate it with biopsy. FibroScan is a very different experience quick, painless, and immediate.

The next step is to understand:

  • What liver stiffness and CAP score actually measure
  • Whether you are a good candidate for the test
  • What your specific result means in context
  • Whether the result changes your current management plan
  • How often the test should be repeated
  • Whether any further testing is needed alongside it

The goal is not simply to “get a number”. It is to use that number, in context, to guide meaningful decisions about your liver health.

Our Approach to FibroScan Assessment

1. Understand What FibroScan Measures

FibroScan uses a technique called transient elastography to assess the liver without any incisions or sedation.

This includes:

  • Liver stiffness (kPa) A higher kPa value generally indicates a greater degree of liver fibrosis, or scarring.
  • CAP score (dB/m) This measures the degree of fat present in the liver, relevant to fatty liver disease (MASLD) in particular.
  • Non-invasive technology The test uses a probe placed on the skin over the liver no needles, no sedation, no recovery time.
  • Immediate results Unlike a biopsy, results are available at the time of the test, allowing decisions to be made in the same visit.

2. Determine Who May Benefit

FibroScan is useful across a broad range of liver conditions, not just one specific disease.

Patients who may benefit include those with:

  • Fatty liver disease (MASLD/MASH) To assess both fat content and the degree of any associated fibrosis.
  • Chronic Hepatitis B or C To help stage liver disease and guide treatment and monitoring decisions.
  • Alcohol-related liver disease To assess the impact of alcohol on liver structure over time.
  • Unexplained abnormal liver tests As part of working out why liver blood tests are abnormal, without an immediate need for biopsy.
  • Known liver disease requiring monitoring To track whether fibrosis is stable, improving or progressing over time, including in response to treatment or lifestyle change.

3. What to Expect During the Test

FibroScan is designed to be quick and comfortable, with minimal preparation required.

  • Simple preparation Patients are generally asked to fast for a few hours beforehand, as eating can affect the accuracy of the reading.
  • A short, painless procedure The test typically takes around ten minutes, with a probe placed against the skin over the right side of the chest.
  • No sedation or recovery time Patients can resume normal activities immediately afterward.
  • Awareness of limitations Factors such as significant obesity, fluid in the abdomen (ascites), or very narrow rib spaces can affect accuracy, and are taken into account when interpreting results.

4. Interpret Results and Plan Next Steps

A FibroScan result is most meaningful when interpreted alongside your full clinical picture, not viewed in isolation.

  • Results in context Liver stiffness and CAP scores are considered together with bloodwork, imaging and clinical history.
  • Reassuring results A low liver stiffness reading is generally reassuring and can reduce the need for further invasive testing.
  • Elevated results Higher readings may prompt further evaluation, which occasionally still includes a biopsy for full clarity in specific situations.
  • Tracking change over time Repeat FibroScan testing is often used to monitor how the liver responds to treatment or lifestyle changes over months or years.

Why Non-Invasive Testing Matters

Being able to assess liver fibrosis without a biopsy has changed how liver disease is monitored, particularly for conditions like fatty liver disease and chronic viral hepatitis, where repeated assessment over time is genuinely valuable. FibroScan makes that ongoing monitoring realistic and accessible in a way biopsy never could be.

A Personalized Plan, Not a One-Size-Fits-All Answer

FibroScan is a powerful tool, but its real value comes from how the result is interpreted for your specific situation. At the practice of Dr. Ashok Choudhury, every FibroScan result is reviewed in the context of your full clinical picture, so the next step is always clear.

If you have been advised to have a FibroScan, or want to discuss whether it is appropriate for your situation, a consultation is the right place to start.

Disclaimer

This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Please consult a qualified healthcare provider regarding your specific condition.